S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
[Urgent!] Generational Wealth Gameplan (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Forget Nvidia, buy this A.I. Stock Now (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
[Urgent!] Generational Wealth Gameplan (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Forget Nvidia, buy this A.I. Stock Now (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
[Urgent!] Generational Wealth Gameplan (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Forget Nvidia, buy this A.I. Stock Now (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
[Urgent!] Generational Wealth Gameplan (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Forget Nvidia, buy this A.I. Stock Now (Ad)
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Urgent alert: open this for a huge profit potential (Ad)
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
Free Trial

Mind Medicine (MindMed) (MNMD) Earnings Date, Estimates & Call Transcripts

→ Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad)
Free MNMD Stock Alerts
$9.53
-0.35 (-3.54%)
(As of 04/17/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
May. 2Estimated
Actual EPS
(Feb. 28)
-$0.59 Missed By -$0.11
Consensus EPS
(Feb. 28)
-$0.48
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MNMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MNMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Mind Medicine (MindMed) Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($1.18)($0.45)($0.73)
Q2 20243($0.49)($0.25)($0.35)
Q3 20243($0.50)($0.28)($0.36)
Q4 20243($0.52)($0.29)($0.40)
FY 202412($2.69)($1.27)($1.84)

MNMD Earnings Date and Information

Mind Medicine (MindMed) last announced its earnings data on February 28th, 2024. The reported ($0.59) earnings per share for the quarter, missing the consensus estimate of ($0.48) by $0.11. Mind Medicine (MindMed) has generated ($2.45) earnings per share over the last year (($2.45) diluted earnings per share). Earnings for Mind Medicine (MindMed) are expected to grow in the coming year, from ($1.70) to ($1.35) per share. Mind Medicine (MindMed) has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

Mind Medicine (MindMed) Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)		------- 
2/28/2024Q4 2023($0.48)($0.59)($0.11)($0.59)--
11/2/2023Q3 2023($0.65)($0.53)+$0.12($0.61)--
8/3/2023Q2 2023($0.54)($0.72)($0.18)($0.68)--
5/4/2023Q1 2023($0.41)($0.51)($0.10)($0.37)--
3/9/2023Q4 2022($0.49)($0.27)+$0.22($0.52)--
11/10/2022Q3 2022($0.58)($0.56)+$0.02($0.56)--
8/11/2022Q2 2022($0.75)($0.60)+$0.15($0.60)--
5/16/2022Q1 2022($0.75)($0.60)+$0.15($0.04)--
3/28/2022Q4 2021-($0.60)($0.60)($0.04)--    
11/12/2021Q3 2021($0.45)($0.90)($0.45)($0.06)--
8/12/2021Q2 2021($0.60)($1.35)($0.75)($0.09)--
5/14/2021Q1 2021-($0.60)($0.60)($0.04)--

Mind Medicine (MindMed) Earnings - Frequently Asked Questions

When is Mind Medicine (MindMed)'s earnings date?

Mind Medicine (MindMed) has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on MNMD's earnings history.

Did Mind Medicine (MindMed) beat their earnings estimates last quarter?

In the previous quarter, Mind Medicine (MindMed) (NASDAQ:MNMD) missed the analysts' consensus estimate of ($0.48) by $0.11 with a reported earnings per share (EPS) of ($0.59). Learn more on analysts' earnings estimate vs. MNMD's actual earnings.

How much profit does Mind Medicine (MindMed) generate each year?

Mind Medicine (MindMed) (NASDAQ:MNMD) has a recorded net income of -$95.73 million. MNMD has generated -$2.45 earnings per share over the last four quarters.

What is Mind Medicine (MindMed)'s EPS forecast for next year?

Mind Medicine (MindMed)'s earnings are expected to grow from ($1.70) per share to ($1.35) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:MNMD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The “Perfect Storm” for Gold
Gold Safe Exchange
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Biden out June 13; Kamala won’t replace him?
Paradigm Press
The #1 Crypto for 2024
InvestorPlace